American Heart Association: Simple Blood Test May Predict Future Heart, Kidney Risk for People With Type 2 Diabetes
August 22, 2023
August 22, 2023
DALLAS, Texas, Aug. 22 (TNSres) -- The American Heart Association issued the following news release:
* * *
Blood levels of four biomarkers for heart and kidney disease fell after treatment with the Type 2 diabetes medicine canagliflozin, according to a new study published in the journal Circulation
Research Highlights:
* An analysis of a clinical trial of more than 2,500 people with Type 2 diabetes and kidney disease found that high levels of f . . .
* * *
Blood levels of four biomarkers for heart and kidney disease fell after treatment with the Type 2 diabetes medicine canagliflozin, according to a new study published in the journal Circulation
Research Highlights:
* An analysis of a clinical trial of more than 2,500 people with Type 2 diabetes and kidney disease found that high levels of f . . .